Evidence map›Paper›PMID 39857971›Full record

ArticleCancers2025

Silicone Fiducial Markers Improve Precision in Uveal Melanoma Radiation Therapy.

Svenja Rebecca Sonntag, Olaf Wittenstein, Oliver Blanck, Jürgen Dunst, Stefan Huttenlocher, Melanie Grehn, Maximilian Busch, Dirk Rades, Ayseguel Tura, Salvatore Grisanti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Svenja Rebecca SonntagDepartment of Ophthalmology, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Olaf WittensteinDepartment of Radiation Oncology, Christian-Albrechts University of Kiel, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.ORCID 0000-0003-4127-3139
Oliver BlanckDepartment of Radiation Oncology, Christian-Albrechts University of Kiel, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Jürgen DunstDepartment of Radiation Oncology, Christian-Albrechts University of Kiel, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Stefan HuttenlocherDepartment of Radiation Oncology, Christian-Albrechts University of Kiel, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.ORCID 0000-0002-6368-3166
Melanie GrehnDepartment of Radiation Oncology, Christian-Albrechts University of Kiel, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.ORCID 0000-0002-6170-5122
Maximilian BuschDepartment of Ophthalmology, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Dirk RadesDepartment of Radiation Oncology, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Ayseguel TuraDepartment of Ophthalmology, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Salvatore GrisantiDepartment of Ophthalmology, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fiducial markersimagingradiotherapytumor delineationuveal melanoma

Identifiers

PMID39857971
PMCPMC11763580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.